CO2023007156A2 - Cápsulas de gel blando de liberación retardada - Google Patents

Cápsulas de gel blando de liberación retardada

Info

Publication number
CO2023007156A2
CO2023007156A2 CONC2023/0007156A CO2023007156A CO2023007156A2 CO 2023007156 A2 CO2023007156 A2 CO 2023007156A2 CO 2023007156 A CO2023007156 A CO 2023007156A CO 2023007156 A2 CO2023007156 A2 CO 2023007156A2
Authority
CO
Colombia
Prior art keywords
soft gel
gel capsules
delayed release
release soft
release
Prior art date
Application number
CONC2023/0007156A
Other languages
English (en)
Spanish (es)
Inventor
Qi Fang
Karunakar Sukuru
Original Assignee
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scherer Technologies Llc R P filed Critical Scherer Technologies Llc R P
Publication of CO2023007156A2 publication Critical patent/CO2023007156A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CONC2023/0007156A 2020-11-11 2023-05-30 Cápsulas de gel blando de liberación retardada CO2023007156A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063112456P 2020-11-11 2020-11-11
PCT/US2021/072325 WO2022104338A1 (en) 2020-11-11 2021-11-10 Delayed release softgel capsules

Publications (1)

Publication Number Publication Date
CO2023007156A2 true CO2023007156A2 (es) 2023-06-20

Family

ID=81601781

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2023/0007156A CO2023007156A2 (es) 2020-11-11 2023-05-30 Cápsulas de gel blando de liberación retardada

Country Status (13)

Country Link
US (1) US20230404927A1 (https=)
EP (1) EP4243786A4 (https=)
JP (1) JP7830458B2 (https=)
KR (1) KR20230106641A (https=)
CN (1) CN116685311A (https=)
AR (1) AR124044A1 (https=)
AU (1) AU2021377907A1 (https=)
CA (1) CA3197516A1 (https=)
CO (1) CO2023007156A2 (https=)
IL (1) IL302751A (https=)
MX (1) MX2023005450A (https=)
TW (1) TW202233165A (https=)
WO (1) WO2022104338A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102022104553A1 (de) * 2022-02-25 2023-08-31 Gelita Ag Magensaftresistente Kapsel und deren Verwendung
KR102785453B1 (ko) * 2022-06-21 2025-03-26 우리바이오(주) 장용성 연질 캡슐용 겔 매스 조성물
AR130183A1 (es) * 2022-08-12 2024-11-13 Scherer Technologies Llc R P Cápsulas blandas entéricas recubiertas
CN120282775A (zh) 2022-12-14 2025-07-08 R·P·谢勒技术有限公司 软凝胶胶囊和制备软凝胶胶囊的方法
JPWO2025009342A1 (https=) * 2023-07-03 2025-01-09
CN120436302A (zh) * 2024-02-08 2025-08-08 仙乐健康科技(广东)有限公司 一种果胶凝胶及其制备方法
WO2025234509A1 (ko) * 2024-05-08 2025-11-13 코스맥스바이오 주식회사 pH 의존성 필름 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0427352A (ja) * 1990-05-22 1992-01-30 Fuji Capsule Kk 健康食品用腸溶性軟カプセル
US5342626A (en) * 1993-04-27 1994-08-30 Merck & Co., Inc. Composition and process for gelatin-free soft capsules
US6340473B1 (en) * 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
US20120301546A1 (en) * 2011-05-26 2012-11-29 Hassan Emadeldin M Acid-resistant soft gel compositions
EP2793867B1 (en) * 2011-12-22 2021-01-20 Baes, Erik Gelatin/alginate delayed release capsules comprising omega-3 fatty acids, and methods and uses thereof
CN104254323A (zh) * 2012-04-13 2014-12-31 旗帜药物胶囊公司 含有片剂和液体或半固体填充剂的软弹性胶囊及其制备方法
US20150366814A1 (en) 2014-06-23 2015-12-24 Banner Life Sciences Llc All-natural enteric soft capsules comprising active ingredients
AU2015329446B2 (en) * 2014-10-06 2017-03-16 Fuji Capsule Co., Ltd. Method of manufacturing enteric soft capsule
US10711119B2 (en) * 2018-01-10 2020-07-14 Cp Kelco Aps Carrageenan-based compositions for films and capsules
US11980691B2 (en) * 2018-03-15 2024-05-14 R.P. Scherer Technologies, Llc Enteric softgel capsules

Also Published As

Publication number Publication date
EP4243786A1 (en) 2023-09-20
CA3197516A1 (en) 2022-05-19
AU2021377907A1 (en) 2023-06-15
WO2022104338A1 (en) 2022-05-19
AR124044A1 (es) 2023-02-08
US20230404927A1 (en) 2023-12-21
KR20230106641A (ko) 2023-07-13
MX2023005450A (es) 2023-05-23
JP7830458B2 (ja) 2026-03-16
TW202233165A (zh) 2022-09-01
EP4243786A4 (en) 2024-10-23
JP2023549177A (ja) 2023-11-22
CN116685311A (zh) 2023-09-01
IL302751A (en) 2023-07-01

Similar Documents

Publication Publication Date Title
CO2023007156A2 (es) Cápsulas de gel blando de liberación retardada
AR100519A1 (es) Envase tipo cápsula de gelatina blanda y su método de fabricación
CL2021003306A1 (es) Agentes, usos y métodos para el tratamiento de la sinucleinopatía. (divisional de solicitud nº 201901293)
CO2023007162A2 (es) Cápsulas de gelatina blanda de liberación retardada
CO2020015153A2 (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos
ECSP22016567A (es) Compuestos inhibidores de rip1 y m?todos para prepararlos y usarlos
MX381741B (es) Envase blister.
MX2018003698A (es) Terapia adjuntiva con 25-hidroxi vitamina d y articulos de los mismos.
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
AR120326A1 (es) CÁPSULAS DE GEL BLANDO DE LIBERACIÓN RETARDADA EN AMBIENTE DE pH ALTO
CR20170142A (es) Composiciones farmacéuticas resistentes al abuso
AR115269A1 (es) Cápsulas de gelatina blanda entéricas
PH12020500641A1 (en) Enteric softgel capsules
CO6630089A2 (es) Composicion de encapsulamiento de liberacion rapida
CL2021003286A1 (es) Cápsula de tipo desintegración retardada y método para producir la misma.
MX2019004554A (es) Forma de dosis farmaceutica de capsula de gelatina blanda con goma guar modificada.
AR122512A1 (es) Cápsulas blandas de liberación retardada
CO2025008948A2 (es) Composición farmacéutica que comprende enavogliflozina y metformina
AR123805A1 (es) Cápsulas blandas de liberación modificada
AR119414A1 (es) Cápsula blanda de gelatina entérica de inhibidor de la bomba de protones
PE20211376A1 (es) Agente terapeutico o profilactico para la mielopatia asociada al htlv-1 (ham), y metodo de tratamiento del ham
CO2021012391A2 (es) Estabilidad api mejorada en capsulas blandas
MX2020005697A (es) Capsula blanda de gel liquido de doble camara y metodo para administrar composiciones de cannabis sublinguales e ingeribles.
CL2017000454A1 (es) Formulación de liberación plurimodal de doxilamina y piridoxina y/o metabolitos o sales de las mismas
AR130183A1 (es) Cápsulas blandas entéricas recubiertas